Form 4: Clover Health Director Carladenise Edwards Reports Acquisition of Restricted Stock Units

Director Carladenise Edwards reports acquisition of 60,975 Class A Common Stock restricted stock units (RSUs) in Clover Health Investments, Corp.

Summary

• On January 6, 2025, Carladenise Edwards, a director of Clover Health Investments, Corp., acquired 60,975 shares of Class A Common Stock in the form of restricted stock units (RSUs).
• These RSUs will vest fully on January 6, 2026, contingent upon Edwards' continued service as a director.
• Following this transaction, Edwards directly owns 473,227 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock ownership change. The RSU grant is a positive sign, but it's not overwhelmingly positive.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs is contingent upon the director's continued service, aligning their interests with the long-term performance of the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers. This filing indicates changes in the beneficial ownership of Clover Health's securities by a director.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment as it reflects the director's continued investment in the company.

Key Dates